|Articles|April 5, 2017
Schulman IRB Partners with iMedRIS to Develop IBC Technology
Schulman IRB announced that research compliance and administration software provider iMedRIS Data is developing the technology to power Schulman’s forthcoming institutional biosafety committee (IBC) service.
Advertisement
Schulman IRB announced that research compliance and administration software provider iMedRIS Data is developing the technology to power Schulman’s forthcoming institutional biosafety committee (IBC) service.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Business Case for DEI in Pharmaceutical Innovation: Why Organizational Commitment Matters for Inclusive Clinical Trials
2
The Evolution of Global Trial Strategies in Today's Complex Healthcare Landscape
3
Why Startup Timelines Are Worsening—and How to Reverse the Trend
4
ACT Brief: Signal Durability Redefines RBQM, AI Targets Startup Friction, and CDMOs Advance Patient-Centric Formulation
5